DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Healthcare Technology Management Market Size, Share & Industry Trends Analysis Report By Type of Services, By Facility Type, By Country and Growth Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific Healthcare Technology Management Market is expected to witness market growth of 11.4% CAGR during the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostics (IVD) Quality Controls: Global Market” report has been added to ResearchAndMarkets.com’s offering. Report Scope The current report provides detailed information regarding the in vitro diagnostics quality controls market. This report highlights the current and future market potential of in vitro diagnostics controls and a detailed analysis of the drivers and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Liver Cancer – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This Liver Cancer – Pipeline Insight, 2022 report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … [Read more…]

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–Lysando AG – market leader in the field of antimicrobial proteins – is pleased to announce that Wilhelm von Haller has joined the team as Chief Financial Officer this March. Baron von Haller is an expert in Corporate Finance, apprenticed during more than 30 years as leading executive in various roles at Deutsche … [Read more…]

– IMscin001 study showed non-inferior levels of cancer immunotherapy Tecentriq in the blood, when injected subcutaneously, compared to intravenous infusion, in people with advanced non-small cell lung cancer – – Administered under the skin, the subcutaneous formulation reduces time spent receiving treatment to just minutes, compared with up to an hour for IV infusion – … [Read more…]

All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead the business as General Manager upon settlement of the offer MELBOURNE, Australia & ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in clinical trial of the Company’s TYK2 JH2 allosteric inhibitor ICP-488 in China. ICP-488 is a potent and selective TYK2 (tyrosine kinase 2) allosteric inhibitor being developed for … [Read more…]

The investment values Kerecis at $620 million REYKJAVIK, Iceland & BILLUND, Denmark & ARLINGTON, Va.–(BUSINESS WIRE)–#kerecis—Kerecis® today announced that it completed its $100 million Series D financing that was led by KIRKBI, the family holding and investment company behind the LEGO Group. Kerecis is the company pioneering the use of sustainably sourced fish skin and … [Read more…]

Partnership provides value-based payment analytics and insights to optimize performance under new Medicare risk arrangement for the Clinically Integrated Network. HONOLULU & LOS ANGELES–(BUSINESS WIRE)–#Medicare–Please replace the second logo of release dated July 28, 2022, with the accompanying corrected logo. The release reads: HAWAII HEALTH NETWORK AND COPE HEALTH SOLUTIONS PARTNER ON POPULATION HEALTH ANALYTICS … [Read more…]

EMERYVILLE, Calif.–(BUSINESS WIRE)–#earnings—Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that effective August 1, 2022, Ligand’s Board of Directors approved the grant of non-qualified stock option awards to purchase an aggregate of 90,073 shares of its common stock, 5,000 restricted stock units (“RSUs”) and 4,000 performance stock units (“PSUs”) (at the target level) to six non-executive … [Read more…]